Skin Laboratory Public Company (SKIN) Fair Value & Analysis
Consumer Defensive · TH · Market cap 117M THB
Fair value as of: Jun 24, 2026
From 22 valuation models · updated 5 days ago
Share price −8.0% over the past month.
Price vs Fair Value (9 months)
9‑month range 0.7715 THB – 3.58 THB · fair‑value band 0.8700 THB – 1.18 THB · the 0.9100 THB price screens below the 1.02 THB fair value. As of Jun 24, 2026.
✦ Which stocks are undervalued right now? Check free Discover now →Analysis
Skin Laboratory Public Company (SKIN) currently trades at 0.9100 THB, while our model-based Fair Value estimate is 1.02 THB — implying the stock looks roughly 12.1% undervalued today. We read business quality at 91/100 (high quality), in the Consumer Defensive sector. Bull case: trading below our estimate, it may offer upside if the fundamentals hold. Bear case: a low price can be a value trap when quality is weak or the data is thin (evidence: high) — always confirm before acting.
Over the trailing twelve months, Skin Laboratory Public Company generated revenue of 167M THB at a net margin of -4.7%. Revenue declined 24.8% year over year. It earns a return on equity of -10.0%. Fundamentals as of Jun 24, 2026
Key figures & financial health
More key figures
Figures from reported company fundamentals (EODHD) · as of Jun 24, 2026. TTM = trailing twelve months.
About the company
Skin Laboratory Public Company Limited manufactures and distributes beauty products in Thailand and internationally. The company offers skincare products, beauty creams, cosmetics, and dietary supplements under the Skinsista and Dermie brand names. It sells its products through online channels and stores. The company was incorporated in 2013 and is headquartered in Nonthaburi, Thailand.
Revenue & earnings trend
FY2022 – FY2025 · reported fiscal years
Skin Laboratory Public Company reported revenue of 177M THB in FY2025 versus 282M THB in FY2022, a compound −14.4%/yr. Reported net income was 4.4M THB in FY2025, compounding −25.8%/yr from FY2022.
Open the full interactive analysis →
Similar stocks
6 more Household & Personal Products stocks, each showing price versus our Fair Value estimate (as of Jun 24, 2026).
| Stock | Price | Fair Value | vs Fair Value |
|---|---|---|---|
| The Procter & Gamble Company PG | 2,590 MXN | 1,415 MXN | -45% |
| L'Oréal S.A LRLCF | $428.02 | $273.79 | -36% |
| Unilever PLC UNLYF | $59.34 | $46.11 | -22% |
| Colgate-Palmolive Company CPA | €77.60 | €36.69 | -53% |
| Hindustan Unilever Limited HINDUNILVR | ₹2,170 | ₹807.38 | -63% |
| Reckitt Benckiser Group RBGLY | $12.41 | $17.31 | +39% |
Explore undervalued stocks
More undervalued Consumer Defensive stocks →
Frequently asked questions
Is Skin Laboratory Public Company (SKIN) undervalued?
What is the fair value of SKIN?
What is the quality score of SKIN?
What is the revenue of Skin Laboratory Public Company (SKIN)?
What is the net profit margin of SKIN?
How we calculate Fair Value
Each company is valued through a stack of independent intrinsic-value models (DCF variants, residual-income, multiples and more), blended into one family-balanced consensus and weighted by how much trustworthy data backs it. A separate quality layer scores the fundamentals. Every input is real reported data — nothing guessed.
Educational research only · not financial advice · no buy/sell recommendation. Model-based estimates are not certainties; their reliability depends on data quality and assumptions.